193 related articles for article (PubMed ID: 22752958)
1. Modified-release prednisone decreases complaints and fatigue compared to standard prednisolone in patients with adrenal insufficiency.
Langenheim J; Ventz M; Hinz A; Quinkler M
Horm Metab Res; 2013 Feb; 45(2):96-101. PubMed ID: 22752958
[TBL] [Abstract][Full Text] [Related]
2. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens.
Bleicken B; Hahner S; Loeffler M; Ventz M; Allolio B; Quinkler M
Eur J Endocrinol; 2008 Dec; 159(6):811-7. PubMed ID: 18819943
[TBL] [Abstract][Full Text] [Related]
3. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
[TBL] [Abstract][Full Text] [Related]
4. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
[TBL] [Abstract][Full Text] [Related]
5. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids.
Cutolo M; Iaccarino L; Doria A; Govoni M; Sulli A; Marcassa C
Clin Exp Rheumatol; 2013; 31(4):498-505. PubMed ID: 23415134
[TBL] [Abstract][Full Text] [Related]
7. A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.
Raine C; Stapleton PP; Merinopoulos D; Maw WW; Achilleos K; Gayford D; Mapplebeck S; Mackerness C; Schofield P; Dasgupta B
Int J Rheum Dis; 2018 Jan; 21(1):285-291. PubMed ID: 28791802
[TBL] [Abstract][Full Text] [Related]
8. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.
Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M
Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in primary and secondary adrenal insufficiency.
Aulinas A; Webb SM
Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):873-88. PubMed ID: 25252879
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Ragnarsson O; Skrtic S; Wahlberg J; Achenbach H; Uddin S; Marelli C; Johannsson G
Eur J Endocrinol; 2017 Jun; 176(6):715-725. PubMed ID: 28292927
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid replacement.
Amin A; Sam AH; Meeran K
BMJ; 2014 Jul; 349():g4843. PubMed ID: 25077828
[No Abstract] [Full Text] [Related]
12. Is physiological glucocorticoid replacement important in children?
Porter J; Blair J; Ross RJ
Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
[TBL] [Abstract][Full Text] [Related]
13. What affects the quality of life in autoimmune Addison's disease?
Meyer G; Hackemann A; Penna-Martinez M; Badenhoop K
Horm Metab Res; 2013 Feb; 45(2):92-5. PubMed ID: 23322510
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
15. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
[TBL] [Abstract][Full Text] [Related]
16. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritis.
Derendorf H; Ruebsamen K; Clarke L; Schaeffler A; Kirwan JR
J Clin Pharmacol; 2013 Mar; 53(3):326-33. PubMed ID: 23444285
[TBL] [Abstract][Full Text] [Related]
18. Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study.
Venneri MA; Hasenmajer V; Fiore D; Sbardella E; Pofi R; Graziadio C; Gianfrilli D; Pivonello C; Negri M; Naro F; Grossman AB; Lenzi A; Pivonello R; Isidori AM
J Clin Endocrinol Metab; 2018 Aug; 103(8):2998-3009. PubMed ID: 29846607
[TBL] [Abstract][Full Text] [Related]
19. Why is the management of glucocorticoid deficiency still controversial: a review of the literature.
Crown A; Lightman S
Clin Endocrinol (Oxf); 2005 Nov; 63(5):483-92. PubMed ID: 16268798
[TBL] [Abstract][Full Text] [Related]
20. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis.
Kirwan JR; Buttgereit F
Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv14-20. PubMed ID: 22685271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
